Compare Corteva Inc. Common Stock (CTVA) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corteva Inc. Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Corteva Inc. Common Stock trades at $13.68 (market cap $9.64B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: Corteva Inc. Common Stock is far larger — about 5.6× Nuvation Bio Inc. Class A Common Stock's market cap, and Corteva Inc. Common Stock pays a 4.98% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corteva Inc. Common Stock for 0 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| CTVA | NUVB | |
|---|---|---|
Market Cap | $9.64B | $1.71B |
Volume | 41,241,255 | 5,448,712 |
Sector | Basic Materials | Health |
52-Week High | $90.51 | $9.54 |
52-Week Low | $11.92 | $3.41 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $12.15B | $1.30B |
Dividend Yield | 4.98% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Corteva Inc. Common Stock
Corteva provides seeds, crop protection products, and digital tools for agriculture. Its products are used by farmers to manage crop production and protect yields.
Read more on CTVA →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
